Naralond, J.J., Kirkwood, J.M., Forget, S.M., Milton, G., Albert, D.M. and Lerner, A.B. (1983) Viltiligo in Patients with Metastatic Melanoma: A Good Prognostic Sign. Journal of the American Academy of Dermatology, 9, 689-696.
http://dx.doi.org/10.1016/S0190-9622(83)70182-9

has been cited by the following article:

• TITLE: Comparative Study on Management of Vitiligo with Psoralen plus Steroid (Oxabet Formula) Alone VS Psoralen Formula plus Narrow Band of Ultraviolet B 311 nm in Khartoum Teaching Hospital of Dermatology and Venereology (KTHDV)

  AUTHORS: Hussein Salman Mohammed, Jahelrasoul Abdalla Edriss

  KEYWORDS: Vitiligo, Oxabet Formula, L.V. (Localize Vitiligo), G.V. ( Generalize Vitiligo), Leukoderma, Psoralen, NB UVB 311nm, PUVA

  JOURNAL NAME: Health, Vol.7 No.12, December 29, 2015

  ABSTRACT: A comparative study and management has been conducted in (KTHDV). For some patients who attend the out patients clinic concern on treatment of the vitiligo with a new formula (Oxabet) alone VS Oxabet (oxpsolaren plus betamethasone) formula plus NB. UVB311 is during a period from (Jan 2011-Jan 2013). The study sample includes different age groups of both sexes. The study revealed that the formula alone gives good results. The localized vitiligo has a good response to the formula than generalized one. The early lesions have good responses than the old ones. The continuations of applying the treatment and the follow up of the patients enhance the efficacy of the treatment.